MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    A 3D CNN Approach for the Classification of Multiple System Atrophy using Multimodal Multicentric MRI

    GM. Mattia, L. Chougar, WG. Meissner, A. Foubert-Samier, A. Pavy-Le Traon, O. Rascol, M. Fabbri, S. Lehéricy, P. Péran (Toulouse, France)

    Objective: To automatically distinguish between healthy controls (HC) and patients with multiple system atrophy (MSA) with a completely automatic approach using a 3D convolutional neural…
  • 2024 International Congress

    String Vessel Formation Regionally Increases in Long Duration Parkinson’s Disease

    D. Dik, GM. Halliday, V. Sytnyk, C. Shepherd (Randwick, Australia)

    Objective: Parkinson's disease is a movement disorder characterised by α-synuclein deposition in the form of Lewy bodies and Lewy neurites. Vascular changes have been thought to contribute…
  • 2024 International Congress

    Oral health in Parkinson’s disease patients from countries with different economies: preliminary results of the OralPark study.

    S. Rota, L. Batzu, A. Biondi, I. Boura, D. Urso, S. Diaconu, Y. Lau, I. Inês, P. Tall, P. Lyra, S. Puspasari, S. Gilani, P. Zinzalias, L. Neumaier, P. Pablo, C. Santoro, S. Landolfo, K. Popławska-Domaszewicz, C. Spanaki, P. Odin, DK. Sreenivas, LK. Prashanth, C. Falup-Pecurariu, A. Rizos, J. Botelho, KR. Chaudhuri (UK, United Kingdom)

    Objective: To characterize oral health in Parkinson’s disease (PD) patients from countries with different economies. Background: Oral diseases are the most frequent conditions globally and…
  • 2024 International Congress

    Association between Antiepileptic Drugs and Parkinson’s Disease: A Strong or Weak Link?

    S. Kharel, SS. Shrestha, SA. Acharya, R. Ojha (Kathmandu, Nepal)

    Objective: To perform a meta-analysis to show the association between different Antiepileptic Drugs(AEDs) and Parkinson’s disease(PD). Background: PD is a neurodegenerative disorder affecting 1-2% of…
  • 2024 International Congress

    Cognitive status in patients with akinetic-rigid and tremor-dominant forms of Parkinson’s disease in Tajikistan.

    M. Mirqosimova (Dushanbe, Tajikistan)

    Objective: To study cognitive impairment in patients with Parkinson's disease (PD) with akinetic-rigid and tremor-dominant forms. Background: Cognitive impairment is a common and debilitating feature…
  • 2024 International Congress

    Attention/Working memory and Executive Tests in Parkinson’s disease: Review, Critique and Recommendations

    R. Biundo, O. Bezdicek, D. Cammisuli, B. Cholerton, JC. Dalrymple-Alford, N. Edelstyn, E. Fiorenzato, E. Holker, SI. Martinez-Horta, A. Martini, G. Santangelo, B. Segura, C. Siri, A. Troster, M. Skorvanek, D. Weintraub, G. Geurtsen (Padova, Italy)

    Objective: To evaluate the clinimetric properties of the Attention/Working memory and Executive domain tests used in Parkinson’s disease (PD) on behalf of the Movement Disorder…
  • 2024 International Congress

    Cognitive profile of Parkinson’s disease (PD) in the Framingham Heart Study (FHS)

    A. Gurnani, J. Dookhy, Y. Liu, Y. Li, S. O'Shea, S. Frank, R. Au, J. Mez, T. Alvin Ang, L. Shih (Framingham, USA)

    Objective: Characterize the cognitive profiles of individuals with PD within a population-based study Background: Understanding the cognitive state of those with PD early in its…
  • 2024 International Congress

    Contrasting Olfactory Perception in Parkinson’s Disease: Impact of GBA1 Gene Mutations

    Y. Schechter, M. Dominko, M. Cohen, G. Yahalom, A. Zimran, S. Revel-Vilk, E. Shulman, T. Dinur, M. Becker Cohen (jerusalem, Israel)

    Objective: To investigate the role of the GBA mutation in smelling perception in PD patients and healthy subjects. Background: Hyposmia is a non-specific sign associated…
  • 2024 International Congress

    Episodes of Hypoglycemia in Patients with Parkinson’s Disease – Results of Two-Week Continuous Glucose Monitoring

    T. Chmiela, A. Gorzkowska (Katowice, Poland)

    Objective: The study aimed to determine the incidence of hypoglycemic episodes in patients with Parkinson's disease (PD) and assess risk factors for these episodes. Background:…
  • 2024 International Congress

    Prospective and Controlled Glucocerebrosidase-related Parkinson’s Disease Evaluation of Non-Motor Symptoms (PROGENS-PD)

    I. Muro, L. López-Manzanares, P. Lorenzo, E. Casas, B. González, J. Masabanda, A. Arroyo, A. Hurtado, JP. Romero (Madrid, Spain)

    Objective: To outline the protocol for an upcoming study aimed at describing the non-motor symptoms (NMS) in Parkinson’s disease (PD) patients with heterozygous glucocerebrosidase (GBA)…
  • 1
  • 2
  • 3
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley